Étienne_Flaubert_Batangu_Mpesa

Étienne Flaubert Batangu Mpesa

Étienne Flaubert Batangu Mpesa

Congolese pharmacist and researcher (1942–2021)

Étienne Flaubert Batangu Mpesa (4 November 1942 – 5 March 2021) was a Congolese pharmacist and scientific researcher.[1][2][3]

Quick Facts Born, Died ...

Biography

Batangu Mpesa earned his pharmaceutical degree from the University of Kinshasa in 1971.[4] He then earned a master's degree in pharmaceutical sciences.[5] In 1980, he founded the Centre de recherche pharmaceutique de Luozi. He later created its website and remained its top researcher.[6] His daughter, Mamyssa Batangu Mpesa, also became a pharmacist.[7]

Batangu Mpesa invented the prescription drug Manadiar,[8][9] which was designed to combat amoebic diarrhea.[10] He also created Manalaria, which helped fight malaria.[11] In November 2020, he had his drug Manacovid,[12][13] approved by the Ministry of Public Health of the Democratic Republic of the Congo.[14] The drug was designed to treat COVID-19.[15][16][17] It has yet to be approved by the World Health Organization.[18]

Étienne Flaubert Batangu Mpesa died of pancreatic cancer in Kinshasa on 5 March 2021 at the age of 78.[19]

References

  1. [1]
    "Qui est l'honorable pharmacien Etienne Flaubert Batangu Mpesa ?". L'Action (in French). 18 May 2020.
  2. [2]
    "Un pharmacien congolais met sur le marché un produit contre la Covid-19". IvoireMatin (in French). 14 January 2021.
  3. [3]
    "RDC : le célèbre pharmacien Batangu Mpesa a échappé à un assassinat". Infobascongo.net (in French). 6 November 2020.
  4. [4]
    "Homologation d'un médicament anticovid dénommé « Manacovid »". mediacongo.net (in French). 16 December 2020.
  5. [5]
    "Le MANACOVID, premier médicament curatif 100% efficace contre la COVID-19". MSN (in French). 13 January 2021.
  6. [6]
    "Après 300 tests réussis, Manacovid médicament congolais contre le covid-19, enfin homologué". Journal des Nations (in French). 14 December 2020.
  7. [7]
    "Étienne Flaubert BATANGU MPESA, géniteur de MANALARIA, MANADIAR et MANACOVID, décédé ce matin". Congo Profond (in French). 5 March 2021.
  8. [8]
    "Homologation en RDC d'un médicament anticovid dénommé « Manacovid »". Actualités congolaises et internationales (in French). 16 November 2020.
  9. [9]
    "RDC : le célèbre pharmacien Batangu Mpesa a échappé à un assassinat". Congo Réformes (in French). 8 November 2020.
  10. [10]
    "MANADIAR 10 COMPR 250MG. Code 11407". Saint Saveur Pharmaceuticals (in French).
  11. [11]
    "MANALARIA 18 COMPR. Code 11409". Saint Saveur Pharmaceuticals (in French).
  12. [12]
    "Le Manacovid, remède miracle des Congolais contre le Coronavirus". Afrik.com (in French). 24 April 2020.
  13. [13]
    "RDC : le pharmacien congolais Batangu lance sur le marché "Manacovid", un produit anti coronavirus". Actualite.cd (in French). 31 December 2020.
  14. [14]
    "Le Manacovid validé lundi par le ministre de la santé". MSN (in French). 11 January 2021.
  15. [15]
    "Homologation en RDC d'un médicament anticovid dénommé « Manacovid »". MSN (in French). 15 December 2020.
  16. [16]
    "Coronavirus : le « Manacovid », le médicament qui fait des miracles en RDC". Ndarinfo (in French). 25 January 2021.
  17. [17]
    "Propositions de traitement du COVID-19". Radio Okapi (in French). 28 April 2020.
  18. [18]
    "Covid-19: la RDC salue deux « produits congolais », l'OMS prudente". La Libre Afrique (in French). 22 January 2021.
  19. [19]
    "RDC : Décès du pharmacien Flaubert Batangu, inventeur du Manacovid19". 7sur7.cd (in French). 5 March 2021.
Flag of Democratic Republic of the CongoBiography icon

This biographical article about a person from the Democratic Republic of the Congo is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Étienne_Flaubert_Batangu_Mpesa, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.